GENESCIENCE PHARMACEUTICALS
GeneScience Pharmaceuticals manufactures recombinant human growth hormone. Its branding product includes GenLei and Jintropin. The company was founded in 1996 and is headquartered in China. Its manufacturing facility covers more than 20,000 sq.m. of land with 11,000 sq.m. of production area.
GENESCIENCE PHARMACEUTICALS
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Euro PHP Pound Sterling Japanese Yen Shockwave Flash Embed
Similar Organizations
Popular Pharmaceuticals
Popular Pharmaceuticals is the manufacturer of Human Insulin in Bangladesh.
Qubit Pharmaceuticals
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santรฉ.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-02-07 | Rani Therapeutics | GeneScience Pharmaceuticals investment in Venture Round - Rani Therapeutics | 53 M USD |
More informations about "GeneScience Pharmaceuticals"
Changchun Genescience Pharmaceuticals Co., Ltd.
Nov 1, 2024 Explore Changchun Genescience Pharmaceuticals Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 136 clinical trials, 3 news, and 16 literature, Disease โฆSee details»
About GeneScience Pharmaceuticals Co., Ltd.. - CPHI โฆ
GeneScience Pharmaceuticals Co Ltd (GenSci) is one of the largest, most profitable and rapidly-growing biopharmaceutical companies in China, with 7 products on the market and over 10 products in the pipeline. GenSci's โฆSee details»
GeneScience Pharmaceuticals Co. - PitchBook
GeneScience Pharmaceuticals Co. General Information Description. Manufacturer of biopharmaceutical drugs based in Changchun, China. The company offers a range of products including somatropin injections, โฆSee details»
GeneScience Pharmaceuticals - Contacts, Employees, Board โฆ
GeneScience Pharmaceuticals manufactures recombinant human growth hormone.See details»
GeneScience Pharmaceuticals Company Profile - Office Locations โฆ
See insights on GeneScience Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
GeneScience Pharmaceuticals - Company Profile - Tracxn
Sep 27, 2024 GeneScience Pharmaceuticals ranks 14th among 60 active competitors. 22 of its competitors are funded while 10 have exited. Overall, GeneScience Pharmaceuticals and its โฆSee details»
GeneScience Pharmaceuticals - Overview, News & Similar
Feb 8, 2018 GeneScience Pharmaceuticals contact info: Phone number: +86 43185195060 Website: www.gensci-china.com What does GeneScience Pharmaceuticals do? GeneScience โฆSee details»
GeneScience Pharmaceuticals Co Ltd DMF, CEP, Written
GeneScience Pharmaceuticals Co Ltd// GeneScience Pharmaceuticals Co., Ltd. (GenSci), was established in 1996. GenSci\'s production facility is located in one of the top 6 national โฆSee details»
GeneScience Pharmaceuticals - Investments, Portfolio & Company โฆ
GeneScience Pharmaceuticals has invested in Rani Therapeutics on Feb 7, 2018. This investment - Venture Round - Rani Therapeutics - was valued at . obfuscated. obfuscated. โฆSee details»
GenSci Launches Global Innovation Hub in Shanghai - BioSpace
SHANGHAI, Dec. 22, 2023 /PRNewswire/ -- Changchun GeneScience Pharmaceutical (โGenSciโ), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking โฆSee details»
GenSci-P122 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 GenSci-P122, Initially developed by Changchun Genescience Pharmaceuticals Co., Ltd., Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms ...See details»
Founder and CEO @ GeneScience Pharmaceuticals - Crunchbase
Primary Organization . GeneScience Pharmaceuticals . Gender Male; Investor Type Investment Partner Lei Jin is the Founder and CEO of GeneScience Pharmaceuticals. Partner โฆSee details»
Genescience Pharmaceuticals describes new FGFR2 and FGFR3 โฆ
Dec 18, 2024 Genescience Pharmaceuticals Co. Ltd. has identified fibroblast growth factor receptor 2 (FGFR2) and/or FGFR3 inhibitors reported to be useful for the treatment of cancer, โฆSee details»
GenSci-P098 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 GenSci-P098, Initially developed by Changchun Genescience Pharmaceuticals Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas ...See details»
Genescience Pharmaceuticals describes new PI3Kฮฑ inhibitors
Oct 17, 2024 Genescience Pharmaceuticals Co. Ltd. has identified phosphatidylinositol 3-kinase ฮฑ (PI3Kฮฑ) inhibitors, particularly PI3Kฮฑ (H1047R mutant), reported to be useful for the โฆSee details»
GenSci098 - Drug Targets, Indications, Patents - Synapse
Dec 27, 2024 Changchun Genescience Pharmaceuticals Co., Ltd. NCT06569758 / Recruiting Phase 1 A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and โฆSee details»
GS-P-328 - Drug Targets, Indications, Patents - Synapse - Patsnap
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
GenSci-P120 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 GenSci-P120, Initially developed by Changchun Genescience Pharmaceuticals Co., Ltd., Now, its global highest R&D status is Discovery, Therapeutic Areas: Immune System ...See details»